Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Elicio Therapeutics, Inc
13G/A
Amendment 1
ELTX · 28657F103
|
5.3% |
7/8/2026
Event 7/1/2026
|
|||
| Knoll Capital Management, LLC | 5.3% | ||||
| Fred Knoll | 5.3% | ||||
| Gakasa Holdings, LLC | 5.3% | ||||
|
Elicio Therapeutics, Inc
13G
ELTX · 28657F103
|
5.2% |
2/5/2025
Event 1/30/2025
|
|||
| Knoll Capital Management, LLC | 5.2% | ||||
| Fred Knoll | 5.2% | ||||
| Gakasa Holdings, LLC | 5.2% | ||||